Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Joint Influence of Recreational Physical Activity and Diet Quality on MAFLD: A National Study of Dose-Response and
1Department of Spine Surgery and Musculoskeletal Tumor Zhongnan Hospital of Wuhan University Wuhan China.
Background And Aims:
Utilizing data from the 2017-2020 National Health and Nutrition Examination Survey (NHANES), this study examined the dose-response relationships and potential synergistic effects of physical activity (PA) and dietary quality (DQ) on the risk of metabolic dysfunction-associated fatty liver disease (MAFLD) among US adults.
Methods:
A nationally representative sample of 6511 participants was analyzed. PA was quantified as weekly recreational physical activity time, and DQ was assessed using the Healthy Eating Index-2015. Weighted multivariable logistic regression models, adjusted for sociodemographic, metabolic, and behavioral confounders, were used to evaluate associations. Dose-response patterns were examined using smooth curve fitting and segmented regression.
Results:
Both higher PA and DQ were independently associated with reduced MAFLD risk (DQ: OR = 0.984, 95% CI = 0.981-0.987; PA: OR = 0.974, 95% CI = 0.969-0.978; both p < 0.0001), with distinct patterns. For PA, each 1-h increase up to 6.776 h/week reduced risk by 9.2% (95% CI: 7.8-10.7%; p < 0.001), with no additional benefit beyond this threshold (p = 0.818). For DQ, each 1-point increase in the Healthy Eating Index-2015 score reduced risk by 0.9% for scores ≤ 50 and by 2.2% for scores > 50. Compared to low PA (≤ 2.5 h/week), moderate (2.5-6.677 h/week) and high PA (> 6.677 h/week) were associated with a 34.1% and 47.7% lower risk, respectively. Moderate and high DQ reduced risk by 15.2% and 38.0% versus low DQ. The combined high-PA/high-DQ group showed the greatest risk reduction (OR = 0.325, 95% CI: 0.278-0.381). In individuals with low DQ, increasing PA from low to high reduced risk by 35.2%-39.3%, whereas improving DQ at low PA levels yielded a more modest reduction (13.4%-29.8%).
Conclusions:
PA and DQ were independently associated with a lower MAFLD risk, with PA exhibiting a threshold effect (optimal at ~400 min/week) and DQ demonstrating cumulative benefits at higher scores. Combining high PA and high DQ yields the strongest protective effect, underscoring the importance of integrated lifestyle interventions for MAFLD prevention.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Atherosclerosis III: Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

